IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 348 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $127,015,340 | +219.3% | 3,095,670 | +178.1% | 0.15% | +202.0% |
| Q1 2023 | $39,780,121 | +281828.6% | 1,113,042 | +197.9% | 0.05% | +150.0% |
| Q4 2022 | $14,110 | -99.9% | 373,586 | +34.9% | 0.02% | +11.1% |
| Q3 2022 | $12,251,000 | +38.9% | 276,977 | +16.2% | 0.02% | +50.0% |
| Q2 2022 | $8,823,000 | +15.6% | 238,339 | +15.6% | 0.01% | +33.3% |
| Q1 2022 | $7,635,000 | +37.0% | 206,141 | +12.6% | 0.01% | +50.0% |
| Q4 2021 | $5,571,000 | +22.4% | 183,087 | +34.9% | 0.01% | +20.0% |
| Q3 2021 | $4,551,000 | – | 135,696 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,541,046 | $126,557 | 6.89% |
| M28 Capital Management LP | 126,300 | $4,513,962 | 5.10% |
| Bellevue Group AG | 9,511,900 | $339,955,306 | 4.93% |
| Deep Track Capital, LP | 2,834,069 | $101,289,626 | 4.16% |
| BVF INC/IL | 2,560,761 | $91,521,598 | 3.35% |
| Sicart Associates LLC | 210,698 | $7,530,347 | 2.93% |
| Privium Fund Management B.V. | 182,773 | $6,532,307 | 2.19% |
| Camber Capital Management LP | 1,925,000 | $68,800 | 2.12% |
| Orbimed Advisors | 2,124,500 | $75,929,630 | 1.49% |
| SECTOR GAMMA AS | 146,441 | $5,233,801 | 1.27% |